Israeli forces uncover and destroy Hamas tunnel network and rocket launchers hidden in Gaza cemetery, raising concerns over militant use of civilian sites.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.
Israeli forces uncover and destroy Hamas tunnel network and rocket launchers hidden in Gaza cemetery, raising concerns over militant use of civilian sites.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise on expanded insurer coverage for new drug Yeztugo.